{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:03:29Z","timestamp":1777982609003,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10147-026-02969-5","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:04:30Z","timestamp":1769497470000},"page":"548-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing pelvic lymph node dissection in bladder cancer: obturator focus, pN1 prognosis, and sentinel node feasibility"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4638-8640","authenticated-orcid":false,"given":"Jun","family":"Miki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahito","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Iwatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Tomomasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Fukuokaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"3","key":"2969_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1200\/jco.2001.19.3.666","volume":"19","author":"JP Stein","year":"2001","unstructured":"Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666\u2013675. https:\/\/doi.org\/10.1200\/jco.2001.19.3.666","journal-title":"J Clin Oncol"},{"issue":"10","key":"2969_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/s1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933. https:\/\/doi.org\/10.1016\/s1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"issue":"1","key":"2969_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.53604","volume":"8","author":"A Kanbergs","year":"2025","unstructured":"Kanbergs A, Melamed A, Viveros-Carre\u00f1o D et al (2025) Surgical deescalation within gynecologic oncology. JAMA Netw Open 8(1):e2453604. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.53604","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2969_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000497310","volume":"103","author":"L Zarifmahmoudi","year":"2019","unstructured":"Zarifmahmoudi L, Ghorbani H, Sadri K et al (2019) Sentinel node biopsy in urothelial carcinoma of the bladder: systematic review and meta-analysis. Urol Int 103(4):373\u2013382. https:\/\/doi.org\/10.1159\/000497310","journal-title":"Urol Int"},{"issue":"1","key":"2969_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.eururo.2006.03.002","volume":"50","author":"A Sherif","year":"2006","unstructured":"Sherif A, Garske U, de la Torre M et al (2006) Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50(1):83\u201391. https:\/\/doi.org\/10.1016\/j.eururo.2006.03.002","journal-title":"Eur Urol"},{"issue":"4","key":"2969_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.urology.2013.11.042","volume":"83","author":"TB Manny","year":"2014","unstructured":"Manny TB, Hemal AK (2014) Fluorescence-enhanced robotic radical cystectomy using unconjugated indocyanine green for pelvic lymphangiography, tumor marking, and mesenteric angiography: the initial clinical experience. Urology 83(4):824\u2013829. https:\/\/doi.org\/10.1016\/j.urology.2013.11.042","journal-title":"Urology"},{"issue":"1","key":"2969_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s0022-5347(05)00066-2","volume":"175","author":"F Liedberg","year":"2006","unstructured":"Liedberg F, Chebil G, Davidsson T et al (2006) Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 175(1):84\u201388. https:\/\/doi.org\/10.1016\/s0022-5347(05)00066-2","journal-title":"J Urol"},{"issue":"2","key":"2969_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67(2):93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"2969_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/iju.70005","author":"S Hara","year":"2025","unstructured":"Hara S, Fukuokaya W, Miki J et al (2025) Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy. Int J Urol. https:\/\/doi.org\/10.1111\/iju.70005","journal-title":"Int J Urol"},{"issue":"6","key":"2969_CR10","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1016\/j.clgc.2017.07.025","volume":"15","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O (2017) Validation of the eighth AJCC new substages for bladder cancer among different staging contexts. Clin Genitourin Cancer 15(6):e1095\u2013e1106. https:\/\/doi.org\/10.1016\/j.clgc.2017.07.025","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"2969_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","volume":"75","author":"JE Gschwend","year":"2019","unstructured":"Gschwend JE, Heck MM, Lehmann J et al (2019) Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur Urol 75(4):604\u2013611. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.047","journal-title":"Eur Urol"},{"issue":"13","key":"2969_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa2401497","volume":"391","author":"SP Lerner","year":"2024","unstructured":"Lerner SP, Tangen C, Svatek RS et al (2024) Standard or extended lymphadenectomy for muscle-invasive bladder cancer. N Engl J Med 391(13):1206\u20131216. https:\/\/doi.org\/10.1056\/NEJMoa2401497","journal-title":"N Engl J Med"},{"issue":"22","key":"2969_CR13","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","volume":"384","author":"DF Bajorin","year":"2021","unstructured":"Bajorin DF, Witjes JA, Gschwend JE et al (2021) Adjuvant Nivolumab versus placebo in muscle-invasive urothelial carcinoma. N Engl J Med 384(22):2102\u20132114. https:\/\/doi.org\/10.1056\/NEJMoa2034442","journal-title":"N Engl J Med"},{"issue":"4","key":"2969_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner GP, Stadler WM, Hansel DE et al (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73(4):560\u2013569. https:\/\/doi.org\/10.1016\/j.eururo.2017.12.018","journal-title":"Eur Urol"},{"issue":"5","key":"2969_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2013.11.040","volume":"66","author":"LA Kluth","year":"2014","unstructured":"Kluth LA, Rieken M, Xylinas E et al (2014) Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 66(5):913\u2013919. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.040","journal-title":"Eur Urol"},{"issue":"1","key":"2969_CR16","doi-asserted-by":"publisher","first-page":"76.e15","DOI":"10.1016\/j.urolonc.2020.07.011","volume":"39","author":"A Drakaki","year":"2021","unstructured":"Drakaki A, Pantuck A, Mhatre SK et al (2021) Real-world\" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma. Urol Oncol 39(1):76.e15-76.e22. https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.011","journal-title":"Urol Oncol"},{"issue":"10","key":"2969_CR17","doi-asserted-by":"publisher","first-page":"333.e331","DOI":"10.1016\/j.urolonc.2024.04.020","volume":"42","author":"L Xia","year":"2024","unstructured":"Xia L, Dadabhoy A, Wood EL et al (2024) Pathologic and survival outcomes following radical cystectomy for \u201cprogressive\u201d and \u201cde novo\u201d muscle-invasive bladder cancer: a meta-analysis stratified by neoadjuvant chemotherapy status. Urol Oncol 42(10):333.e331-333.e313. https:\/\/doi.org\/10.1016\/j.urolonc.2024.04.020","journal-title":"Urol Oncol"},{"issue":"6","key":"2969_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.urolonc.2018.03.018","volume":"36","author":"A Mari","year":"2018","unstructured":"Mari A, Kimura S, Foerster B et al (2018) A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. Urol Oncol 36(6):293\u2013305. https:\/\/doi.org\/10.1016\/j.urolonc.2018.03.018","journal-title":"Urol Oncol"},{"issue":"1","key":"2969_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.juro.2008.03.024","volume":"180","author":"MA Ghoneim","year":"2008","unstructured":"Ghoneim MA, Abdel-Latif M, el- M et al (2008) Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 180(1):121\u2013127. https:\/\/doi.org\/10.1016\/j.juro.2008.03.024","journal-title":"J Urol"},{"issue":"1","key":"2969_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"6","key":"2969_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/pros.23486","volume":"78","author":"J Miki","year":"2018","unstructured":"Miki J, Yanagisawa T, Tsuzuki S et al (2018) Anatomical localization and clinical impact of sentinel lymph nodes based on patterns of pelvic lymphatic drainage in clinically localized prostate cancer. Prostate 78(6):419\u2013425. https:\/\/doi.org\/10.1002\/pros.23486","journal-title":"Prostate"},{"issue":"4","key":"2969_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.eururo.2016.09.007","volume":"71","author":"EMK Wit","year":"2017","unstructured":"Wit EMK, Acar C, Grivas N et al (2017) Sentinel node procedure in prostate cancer: a systematic review to assess diagnostic accuracy. Eur Urol 71(4):596\u2013605. https:\/\/doi.org\/10.1016\/j.eururo.2016.09.007","journal-title":"Eur Urol"},{"issue":"1","key":"2969_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/ases.13274","volume":"17","author":"I Takemasa","year":"2024","unstructured":"Takemasa I, Hamabe A, Takenaka A et al (2024) Standardization of robot-assisted pelvic lymph node dissection-development of a common understanding of regional anatomy and surgical technique based on cross-disciplinary discussion among colorectal surgery, urology, and gynecology. Asian J Endosc Surg 17(1):e13274. https:\/\/doi.org\/10.1111\/ases.13274","journal-title":"Asian J Endosc Surg"},{"key":"2969_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/iju.15563","author":"S Morizane","year":"2024","unstructured":"Morizane S, Miki J, Shimbo M et al (2024) Japanese expert consensus on the standardization of robot-assisted pelvic lymph node dissection in urological surgery: extent of pelvic lymph node and surgical technique. Int J Urol. https:\/\/doi.org\/10.1111\/iju.15563","journal-title":"Int J Urol"},{"issue":"2","key":"2969_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2214\/ajr.20.22997","volume":"217","author":"CK Pedersen","year":"2021","unstructured":"Pedersen CK, Babu AS (2021) Understanding the lymphatics: an updated review of the N category of the AJCC 8th edition for urogenital cancers. AJR Am J Roentgenol 217(2):368\u2013377. https:\/\/doi.org\/10.2214\/ajr.20.22997","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"2969_CR26","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1007\/s00261-019-02285-9","volume":"45","author":"A O'Shea","year":"2020","unstructured":"O\u2019Shea A, Kilcoyne A, Hedgire SS et al (2020) Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies. Abdom Radiol (NY) 45(7):2198\u20132212. https:\/\/doi.org\/10.1007\/s00261-019-02285-9","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"2969_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.ju.0000102302.26806.fb","volume":"171","author":"J Leissner","year":"2004","unstructured":"Leissner J, Ghoneim MA, Abol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171(1):139\u2013144. https:\/\/doi.org\/10.1097\/01.ju.0000102302.26806.fb","journal-title":"J Urol"},{"issue":"2","key":"2969_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.juro.2009.09.080","volume":"183","author":"PP Dangle","year":"2010","unstructured":"Dangle PP, Gong MC, Bahnson RR et al (2010) How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 183(2):499\u2013503. https:\/\/doi.org\/10.1016\/j.juro.2009.09.080","journal-title":"J Urol"},{"issue":"5","key":"2969_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A et al (2025) European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines. Eur Urol 87(5):582\u2013600. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.019","journal-title":"Eur Urol"},{"issue":"11","key":"2969_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41585-018-0066-1","volume":"15","author":"M Perera","year":"2018","unstructured":"Perera M, McGrath S, Sengupta S et al (2018) Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer. Nat Rev Urol 15(11):686\u2013692. https:\/\/doi.org\/10.1038\/s41585-018-0066-1","journal-title":"Nat Rev Urol"},{"issue":"2","key":"2969_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.eururo.2009.10.026","volume":"57","author":"B Roth","year":"2010","unstructured":"Roth B, Wissmeyer MP, Birkh\u00e4user P et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57(2):205\u2013211. https:\/\/doi.org\/10.1016\/j.eururo.2009.10.026","journal-title":"Eur Urol"},{"issue":"5","key":"2969_CR32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.juro.2011.12.106","volume":"187","author":"B Roth","year":"2012","unstructured":"Roth B, Zehnder P, Birkh\u00e4user P et al (2012) Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol 187(5):1577\u20131582. https:\/\/doi.org\/10.1016\/j.juro.2011.12.106","journal-title":"J Urol"},{"key":"2969_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175127","author":"A Gurwin","year":"2024","unstructured":"Gurwin A, Karwacki J, Dorochowicz M et al (2024) Topography and lateralization of nodal metastases in muscle-invasive bladder cancer using super-extended pelvic lymph node dissection with the sentinel lymph node technique. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13175127","journal-title":"J Clin Med"},{"issue":"1","key":"2969_CR34","doi-asserted-by":"publisher","first-page":"21.e29","DOI":"10.1016\/j.urolonc.2023.09.009","volume":"42","author":"L Sodagum","year":"2024","unstructured":"Sodagum L, Passarelli R, Pfail J et al (2024) Pelvic lymphadenectomy: evaluating nodal stage migration and will rogers effect in bladder cancer. Urol Oncol 42(1):21.e29-21.e20. https:\/\/doi.org\/10.1016\/j.urolonc.2023.09.009","journal-title":"Urol Oncol"},{"issue":"1","key":"2969_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1200\/jco.24.00340","volume":"43","author":"MD Galsky","year":"2025","unstructured":"Galsky MD, Witjes JA, Gschwend JE et al (2025) Adjuvant Nivolumab in high-risk muscle-invasive urothelial carcinoma: expanded efficacy from CheckMate 274. J Clin Oncol 43(1):15\u201321. https:\/\/doi.org\/10.1200\/jco.24.00340","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-02969-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:04:11Z","timestamp":1771952651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-02969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-02969-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7458941\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takahiro Kimura has received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Sanofi, and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The institutional review board approved the study protocol 36\u2013005[12104].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study registration"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}